Recent Updates
Recently added Catalysts
IART Positive Sentiment Score: 85/100

Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

Key Takeaway: Integra LifeSciences has received FDA 510(k) clearance for its CUSA Clarity Ultrasonic Surgical Aspirator System, allowing its use in cardiac surgeries, including valve replacement and repair. This clearance signifies an important expansion of the system's applications. The company will showcase the system at an upcoming thoracic surgery conference in December 2025.
Price reaction · baseline $12.33 (2025-11-11 close) · hit after-hours · clean, no other IART news in the window
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA 510(k) clearance expands the CUSA Clarity's applications.
  • System enhances surgical solutions for cardiac procedures.
  • Integra LifeSciences is recognized as an industry leader.

Full Press Release Details

PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) --Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce the FDA 510(k) clearance for use of itsCUSA®Clarity Ultrasonic Surgical Aspirator Systemfor cardiac surgeries. The recent clearance for specific cardiac indications encompasses the debridement of unwanted tissue in cardiac surgeries, including valve replacement and repair.
In addition to cardiac surgery, the CUSA Clarity Ultrasonic Surgical Aspirator System is indicated for use in surgical procedures where fragmentation, emulsification and aspiration of soft and hard (e.g. bone) tissue is desirable, such as neurosurgery, plastic and reconstructive surgery, orthopedic surgery, thoracic surgery, laparoscopic surgery, gynecological surgery, and liver resection and transplant surgery.
“The utilization of CUSA Clarity for cardiac surgery marks the next pivotal expansion of the ultrasonic surgical aspirator system’s breadth of indications,” said Mike McBreen, executive vice president and president of Integra’s Codman Specialty Surgical division. “As one of the leaders in the industry, this milestone strengthens our ability to deliver advanced surgical solutions to support restoring patients’ lives.”
Integra LifeSciences will spotlight the CUSA Clarity Ultrasonic Surgical Aspirator System at the American Association for Thoracic Surgeon Mitral Valve Conclave in New York City on December 11 and 12, 2025.
About Integra LifeSciencesIntegra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies is trusted by healthcare professionals to deliver transformative care. For the latest news and information about Integra and its products, please visitwww.integralife.com.

Investor Relations:Chris Ward(609) 772-7736chris.ward@integralife.com

Media Contact:Laurene Isip(609) 208-8121laurene.isip@integralife.com

Frequently Asked Questions

What is the CUSA Clarity Ultrasonic Surgical Aspirator System?

The CUSA Clarity is a surgical aspirator system used for debridement and tissue aspiration in various surgical procedures.

What recent clearance did Integra LifeSciences receive?

Integra LifeSciences received FDA 510(k) clearance for the CUSA Clarity for use in cardiac surgeries.

When will the CUSA Clarity be showcased?

The CUSA Clarity will be highlighted at the American Association for Thoracic Surgeons Mitral Valve Conclave on December 11-12, 2025.

What types of surgeries can use the CUSA Clarity?

The system is indicated for cardiac, neurosurgery, orthopedic, and other surgical procedures.

Last updated: Nov 11, 2025